Reanalysis of Cancer Drugs

This publication has 61 references indexed in Scilit:

• Cancer Statistics, 2004
  CA: A Cancer Journal for Clinicians, 2004
• Core binding factor (CBF) acute myeloid leukemia: is molecular monitoring by RT–PCR useful clinically?
  European Journal of Haematology, 2003
• Molecular imaging in drug discovery and development
  Nature Reviews Drug Discovery, 2003
• A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
  New England Journal of Medicine, 2002
• Quantitative real-time RT-PCR detects elevated Wilms tumor gene (WT1) expression in autologous blood stem cell preparations (PBSCs) from acute myeloid leukemia (AML) patients indicating contamination with leukemic blasts
  Bone Marrow Transplantation, 2002
• Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia
  The Journal of Experimental Medicine, 2001
• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
  Nature, 2000
• Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemia
  Leukemia, 2000
• Additional value of K‐ras point mutations in bronchial wash fluids for diagnosis of peripheral lung tumours
  European Respiratory Journal, 1999
• Drug target validation and identification of secondary drug target effects using DNA microarrays
  Nature Medicine, 1998